Remus Pharmaceuticals Ltd

NSE: REMUS · Pharmaceuticals & Biotechnology · 26 announcements

Share price

₹798.90

Market cap

₹941.4 Cr

Revenue (annual)

₹853.6 Cr

Net profit (annual)

₹36.99 Cr

P/E (TTM)

25.4×Sector 43.8×

Promoter holding

70.95%

FII holding

5.10%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.